Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04640714 · ClinicalTrials.gov registry record · NA
Care Transition Intervention for Patients With Cancer
A NA study of Advanced Cancer and Home Care, Hospital-Based, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 1
- Study location
NCT04640714: Completed NA study of Advanced Cancer and Home Care, Hospital-Based, sponsored by Massachusetts General Hospital.
NCT04640714 is a NA study of Advanced Cancer and Home Care, Hospital-Based that has completed, run by Massachusetts General Hospital. The registered enrollment target is 58 participants, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04640714, a NA study of Advanced Cancer and Home Care, Hospital-Based, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is investigating an intervention called CONTINUity of care Under Management by Video visits (CONTINUUM-V). CONTINUUM-V involves a video visit with an oncology nurse practitioner within three business days of hospital discharge for patients with advanced cancer with the goal of reducing burdensome care transitions after hospitalization, including hospital readmissions.
Primary Outcome
The intervention will be deemed feasible if at least 70% of eligible patients participate in the study, and if at least 70% complete the video visit within three business days of discharge.
Conditions Studied
Interventions
- BEHAVIORAL CONTINUity of care Under Management by Video visits (CONTINUUM-V)
Study Locations (1)
Massachusetts
- Massachusetts General Hospital Cancer Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2021-01-07 |
| Est. Completion | 2021-07-14 |
| Phase | NA |
What the finished NCT04640714 record still lists
NCT04640714 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with Advanced Cancer appearing as the primary indexed condition, and to 1 intervention - of which CONTINUity of care Under Management by Video visits (CONTINUUM-V) is the first listed.
NCT04640714 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04640714 about?
NCT04640714 is a clinical study titled "Care Transition Intervention for Patients With Cancer". This research study is investigating an intervention called CONTINUity of care Under Management by Video visits (CONTINUUM-V). CONTINUUM-V involves a video visit with an oncology nurse practitioner within three business days of hospital discharge for patients with advanced cancer with the goal of re...
What is the current status of trial NCT04640714?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2021-01-07. Estimated completion is 2021-07-14.
What conditions does trial NCT04640714 study?
This clinical trial studies the following conditions: Advanced Cancer, Home Care, Hospital-Based.
What interventions are being tested in trial NCT04640714?
The interventions under investigation include: CONTINUity of care Under Management by Video visits (CONTINUUM-V) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04640714?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04640714 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04640714's enrollment target sits among peer trials
58 82nd of 122 higher than 41 of 122 other Advanced Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Advanced Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
RECRUITING · NA
-
Pilot Trial of Spiritual Care Interventions for Patients With Cancer
RECRUITING · NA
-
Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care Services
RECRUITING · NA
-
ALIGN for Older Adults With Cancer in SNFs
RECRUITING · NA
-
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI